Search - tctmd.com

Displaying 101 - 113 of 113

Sort: Relevancy | Date

News Daily News

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

Jason Kahn

February 20, 2014

News Daily News

DAPT Interruption At Least 1 Month After ZES Implantation Appears Safe

Yael L. Maxwell

February 17, 2014

News Daily News

Stent Malapposition Frequent, But Without Clinical Consequences

Jason Kahn

January 27, 2014

News Daily News

La Mala Aposición del Stent es algo Frecuente que No tiene Consecuencias Clínicas

Jason Kahn

January 27, 2014

Presentation TCT 2013

Perhaps, but It May Depend on Using an Optimized Bare Metal Stent Platform!

Presenter: Julio Palmaz

October 27, 2013

News Conference News EuroPCR 2013

Paclitaxel Delivery Key to PAD Intervention

Caitlin E. Cox

May 22, 2013

News Daily News

Colchicine Reduces BMS Restenosis in Diabetic Patients

April 19, 2013

News Daily News

ISAR-DESIRE 3 Published: Paclitaxel-Eluting Balloons Match PES for DES Restenosis

Caitlin E. Cox

February 07, 2013

News Industry News

Abbott Announces CE Mark and European Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent

August 20, 2012

News Industry News

Cardionovum® expects to launch next-generation product: drug-eluting coronary stent system, PROLIMUS Biograde

August 08, 2012

News Daily News

Some New-Generation Stents Prone to Longitudinal Distortion

November 29, 2011

News Daily News

In Vivo Study Suggests DES Polymer-Drug Coatings Not Inherently Thrombogenic

Caitlin E. Cox

March 25, 2011

News Daily News

Benefit of Sirolimus Stents Sharply Attenuated in Dialysis Patients

January 04, 2011

Advertisement

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

DAPT Interruption At Least 1 Month After ZES Implantation Appears Safe

Stent Malapposition Frequent, But Without Clinical Consequences

La Mala Aposición del Stent es algo Frecuente que No tiene Consecuencias Clínicas

Perhaps, but It May Depend on Using an Optimized Bare Metal Stent Platform!

Paclitaxel Delivery Key to PAD Intervention

Colchicine Reduces BMS Restenosis in Diabetic Patients

ISAR-DESIRE 3 Published: Paclitaxel-Eluting Balloons Match PES for DES Restenosis

Abbott Announces CE Mark and European Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent

Cardionovum® expects to launch next-generation product: drug-eluting coronary stent system, PROLIMUS Biograde

Some New-Generation Stents Prone to Longitudinal Distortion

In Vivo Study Suggests DES Polymer-Drug Coatings Not Inherently Thrombogenic

Benefit of Sirolimus Stents Sharply Attenuated in Dialysis Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content